← Back to portfolio Porfolio / Arcinova

Arcinova

Pharmaceutical research and development company

Company overview

Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.

Website

arcinova.uk

This is an exciting time for Arcinova. We have a fantastic team, a world-class facility and strong market opportunity. We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on a period of capital expenditure and international expansion.

Professor Ian Shott, executive chair

Business funding insights

June 2021 Insights

BGF explains: Is private equity the best way to fund an M&A growth strategy?

What to consider when seeking private equity funding for acquisitive growth, from investment timelines to deal types and more

Business funding

June 2021 Insights

BGF explains: what do private equity investors look for in a business?

We explain what private equity investors look for in the businesses they invest in, from your growth plan to your management team.

Business funding

May 2021 Insights

BGF explains: buy and build

We explain what ‘buy and build’ means and why businesses choose to pursue this kind of strategy

Business funding

Arcinova

Company overview

Website

Company information

Head office

CEO

Chair

BGF office

BGF team

Investment date

Total BGF investment

Business funding insights

BGF explains: Is private equity the best way to fund an M&A growth strategy?

BGF explains: what do private equity investors look for in a business?

BGF explains: buy and build